← Leaderboards
Jonah R Chan
University Of California, San Francisco
$10,552,085
Attributed
$14,366,772
Total exposure
8
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.1M · FY2008–25$2.5M$1.9M$1.3M$625K$0
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$14,366,772 · 8
By mechanism
R01$13,871,560 · 6
R21$451,000 · 1
F32$44,212 · 1
Top collaborators
- Mazen A Kheirbek5 shared
- Elior Peles5 shared
- Adam R. Abate3 shared
- Carlo L Condello3 shared
- Bridget Lamonica Ostrem1 shared
Most similar at University Of California, San Francisco
Same institution · by research overlap
- Tanuj Gulati$2,163,012
- Ari J Green$2,473,192
- Sonia R Mayoral$887,744
- Arthur Weiss$25,258,536
- Scott S Zamvil$12,721,345
Others in their field
Top investigators on “Myelination”
- James J Lah · Emory University$35,158,235
- Stephen Arthur Back · Oregon Health & Science University$23,494,618
- Vijay K Kuchroo · Brigham And Women'S Hospital$22,841,024
- Jeff W Lichtman · Washington University$21,489,807
- Bruce D Trapp · Cleveland Clinic Lerner Com-Cwru$21,079,355
- Brian J Popko · Northwestern University$20,097,136
Research focus
MyelinationMyelinAxonCellsNeuronsMembraneMolecularSignal TransductionKnockout MiceOligodendrogliaInsightGenerationsComplexMediatingNeurotransmissionReceptorMultiple SclerosisBasePathway InteractionsAffectRegulationAdultScaffoldIn Vivo
Grant awards (37)
Cell-type, circuit and network mechanisms of adult oligodendrogenesis in memory storage and retrieval$668,005
R01 · FY2025 · MH
Identification of Regulatory Mechanisms Operating in Rare Pathogenic Astrocyte Subsets in Multiple Sclerosis with a Novel Genomic Technology$573,663
R01 · FY2025 · NS
Neuropeptides as axonal determinants for oligodendrocyte differentiation and myelination$361,665
R01 · FY2025 · NS · contact PI
Cell-type, circuit and network mechanisms of adult oligodendrogenesis in memory storage and retrieval$722,100
R01 · FY2024 · MH
Identification of regulatory mechanisms operating in rare pathogenic astrocyte subsets in multiple sclerosis with a novel genomic technology$556,336
R01 · FY2024 · NS
Investigating the therapeutic potential of maternal breast milk components for preterm white matter injury$451,000
R21 · FY2024 · HD · contact PI
Neuropeptides as axonal determinants for oligodendrocyte differentiation and myelination$388,933
R01 · FY2024 · NS · contact PI
Cell-type, circuit and network mechanisms of adult oligodendrogenesis in memory storage and retrieval$694,994
R01 · FY2023 · MH
Identification of regulatory mechanisms operating in rare pathogenic astrocyte subsets in multiple sclerosis with a novel genomic technology$573,422
R01 · FY2023 · NS
Neuropeptides as axonal determinants for oligodendrocyte differentiation and myelination$400,099
R01 · FY2023 · NS · contact PI
Cell-type, circuit and network mechanisms of adult oligodendrogenesis in memory storage and retrieval$694,994
R01 · FY2022 · MH
Neuropeptides as axonal determinants for oligodendrocyte differentiation and myelination$399,261
R01 · FY2022 · NS · contact PI
Cell-type, circuit and network mechanisms of adult oligodendrogenesis in memory storage and retrieval$656,836
R01 · FY2021 · MH
Neuropeptides as axonal determinants for oligodendrocyte differentiation and myelination$398,448
R01 · FY2021 · NS · contact PI
Functional Screening of GPCR Small Molecule Libraries for Remyelination Therapies$346,719
R01 · FY2020 · NS · contact PI
Somatodendritic Inhibition of Oligodendrocyte Myelination$291,484
R01 · FY2020 · NS · contact PI
Functional Screening of GPCR Small Molecule Libraries for Remyelination Therapies$346,719
R01 · FY2019 · NS · contact PI
Somatodendritic Inhibition of Oligodendrocyte Myelination$291,484
R01 · FY2019 · NS · contact PI
Functional Screening of GPCR Small Molecule Libraries for Remyelination Therapies$160,666
R01 · FY2019 · NS · contact PI
Functional Screening of GPCR Small Molecule Libraries for Remyelination Therapies$346,719
R01 · FY2018 · NS · contact PI
The establishment of Schwann cell polarity and the initiation of myelination$344,750
R01 · FY2018 · NS · contact PI
Somatodendritic Inhibition of Oligodendrocyte Myelination$291,484
R01 · FY2018 · NS · contact PI
Functional Screening of GPCR Small Molecule Libraries for Remyelination Therapies$346,719
R01 · FY2017 · NS · contact PI
The establishment of Schwann cell polarity and the initiation of myelination$344,750
R01 · FY2017 · NS · contact PI
Somatodendritic Inhibition of Oligodendrocyte Myelination$291,484
R01 · FY2017 · NS · contact PI
The establishment of Schwann cell polarity and the initiation of myelination$344,750
R01 · FY2016 · NS · contact PI
Functional Screening of GPCR Small Molecule Libraries for Remyelination Therapies$342,947
R01 · FY2016 · NS · contact PI
Somatodendritic Inhibition of Oligodendrocyte Myelination$304,281
R01 · FY2016 · NS · contact PI
The establishment of Schwann cell polarity and the initiation of myelination$344,633
R01 · FY2015 · NS · contact PI
The establishment of Schwann cell polarity and the initiation of myelination$356,468
R01 · FY2014 · NS · contact PI
THE ESTABLISHMENT OF SCHWANN CELL POLARITY AND THE INITIATION OF MYELINATION$326,579
R01 · FY2012 · NS · contact PI
THE ESTABLISHMENT OF SCHWANN CELL POLARITY AND THE INITIATION OF MYELINATION$326,714
R01 · FY2011 · NS · contact PI
THE ESTABLISHMENT OF SCHWANN CELL POLARITY AND THE INITIATION OF MYELINATION$330,180
R01 · FY2010 · NS · contact PI
THE ESTABLISHMENT OF SCHWANN CELL POLARITY AND THE INITIATION OF MYELINATION$287,312
R01 · FY2009 · NS · contact PI
THE ESTABLISHMENT OF SCHWANN CELL POLARITY AND THE INITIATION OF MYELINATION$64,252
R01 · FY2009 · NS · contact PI
THE ESTABLISHMENT OF SCHWANN CELL POLARITY AND THE INITIATION OF MYELINATION$351,710
R01 · FY2008 · NS · contact PI
Neurotrophins and the Myelination Program of the PNS$44,212
F32 · FY2002 · NS